| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521754A2 Viral inhibitors |
| 04/13/2005 | EP1521595A1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 04/13/2005 | EP1521590A1 Novel medicament combinations based on magnesium salts and fibrinolytics |
| 04/13/2005 | EP1521588A2 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 04/13/2005 | EP1521583A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives |
| 04/13/2005 | EP1521580A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 04/13/2005 | EP1521579A1 Novel medicament combinations based on sodium channel blockers and magnesium salts |
| 04/13/2005 | EP1521576A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors |
| 04/13/2005 | EP1476193A4 A weight management system for obese animals |
| 04/13/2005 | EP1474171A4 Weight management system for obese animals |
| 04/13/2005 | EP1365776B1 Use of an adenosine a3 receptor agonist for inhibition of viral replication |
| 04/13/2005 | EP1268498B1 Cardioprotective phosphonates |
| 04/13/2005 | EP1214101A4 Method for detecting and killing epithelial cancer cells |
| 04/13/2005 | EP1196136B1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 04/13/2005 | EP1077709B1 Arsenic sulfide compounds free of arsenic oxide for the treatment of hematological cancers |
| 04/13/2005 | EP1059917B1 Pharmaceutical preparation for use in anti-asthma therapy |
| 04/13/2005 | EP1033982B1 Agents for combating neospora spec |
| 04/13/2005 | EP1023312A4 Method for modulating gene expression |
| 04/13/2005 | EP1017408B1 Use of tethrahydrolipstatin in the treatment of diabetes type ii |
| 04/13/2005 | EP0871488B1 Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and a kappa-2 opioid agonist |
| 04/13/2005 | CN1606694A Methods for monitoring and treating amyotrophic lateral sclerosis |
| 04/13/2005 | CN1606620A Slow releasing protein polymer |
| 04/13/2005 | CN1606563A Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606463A Methods of treating bacterial infections in dogs and cats |
| 04/13/2005 | CN1606449A Improved use of antitumoral compound in cancer therapy |
| 04/13/2005 | CN1606441A Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/13/2005 | CN1606436A Compounds and methods of treating transplant rejection |
| 04/13/2005 | CN1606427A Stable surfactant compositions for suspending components |
| 04/13/2005 | CN1196797C Diagnostics and therapeutics for glaucoma |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/13/2005 | CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 04/13/2005 | CN1196488C Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 04/13/2005 | CN1196487C 单位剂量形式 The unit dosage form |
| 04/13/2005 | CN1196485C Compositions for use against parasitic protozoa |
| 04/13/2005 | CN1196483C Compositions for improivng fertility |
| 04/13/2005 | CN1196478C Combinations of formoterol and mometasone furoate for asthma |
| 04/12/2005 | US6878817 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 04/12/2005 | US6878808 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 04/12/2005 | US6878751 Administration of resveratrol to treat inflammatory respiratory disorders |
| 04/12/2005 | US6878734 Gastrin and cholecystokinin receptor ligands(II) |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878728 Sulfonamides containing a tetrahydrofurodihydrofuranyl-O-carbonylamino group; particularly for treating HIV viral infections |
| 04/12/2005 | US6878713 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878703 Mixture with diuretics; hypotensive agents |
| 04/12/2005 | US6878698 Anti-inflammatory androstane derivatives |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | US6878526 Treating cancer |
| 04/12/2005 | US6878522 Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| 04/12/2005 | US6878373 Probiotic composition containing Bacillus cereus RRRL B-30535 |
| 04/12/2005 | CA2385854C Formulation for menopausal women |
| 04/12/2005 | CA2278106C Tissue factor methods and compositions for coagulation and tumor treatment |
| 04/12/2005 | CA2252576C Use of dipeptidyl peptidase iv inhibitors for lowering the blood glucose level in mammals |
| 04/07/2005 | WO2005030776A1 Pyrazolopyrrole derivatives as protein kinase inhibitors |
| 04/07/2005 | WO2005030256A1 INHIBITION OF NERVE CELL DEATH BY INHIBITING DEGRADATION OF SHC3, ATF6 OR CREBL1 BY HtrA2 AND METHOD OF AMELIORATING NEURODEGENERATIVE DISEASES |
| 04/07/2005 | WO2005030255A1 METHOD OF TREATING DIABETES BY INHIBTING DEGRADATION OF AT LEAST ONE OF CREBL1, ATF6 and HNF-4α BY HtrA2 |
| 04/07/2005 | WO2005030239A2 Antitumor agent comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor |
| 04/07/2005 | WO2005030225A2 Method of inhibiting the expression of a multi-drug resistance genes and inhibiting the production of proteins resulting from the expression of such genes thereby enhancing the effectiveness of chemotherapeutic agents to treat cancers |
| 04/07/2005 | WO2005030205A1 Ocular solutions containing a macrolide antibiotic and/or mycophenolic acid |
| 04/07/2005 | WO2005030194A1 Hcv inhibitiing sulfonamides |
| 04/07/2005 | WO2005030187A2 Iloprost in combination therapies for the treatment of pulmonary arterial hypertension |
| 04/07/2005 | WO2005030181A1 Controlled release formulations of opioid and nonopioid analgesics |
| 04/07/2005 | WO2005030168A1 Skin burn treatment ointment |
| 04/07/2005 | WO2005030144A2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 04/07/2005 | WO2005030133A2 Treatment with agonists of toll-like receptors |
| 04/07/2005 | WO2005030132A2 Therapeutic regimens for administering drug combinations |
| 04/07/2005 | WO2005030118A2 Targeted release of nitric oxide in the cns circulation for modulating the bbb and treating disorders |
| 04/07/2005 | WO2005016960A3 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 04/07/2005 | WO2005009472A3 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 04/07/2005 | WO2005009342A3 Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
| 04/07/2005 | WO2004113286A3 Mucin synthesis inhibitors |
| 04/07/2005 | WO2004112756A8 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| 04/07/2005 | WO2004110383A3 Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy |
| 04/07/2005 | WO2004096206A3 Therapeutic combination of a cox-2 inhibitor and a tace inhibitor |
| 04/07/2005 | WO2004093795A3 Compositions for delivery of drug combinations |
| 04/07/2005 | WO2004091596A3 Combination therapies for chronic obstructive pulmonary disease (copd) |
| 04/07/2005 | WO2004062624A3 Method of treating nausea, vomiting, retching or any combination thereof |
| 04/07/2005 | WO2004030618A3 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 04/07/2005 | WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 04/07/2005 | WO2004006847A3 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 04/07/2005 | WO2004002422A3 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 04/07/2005 | WO2004001072A3 Method for diagnosis of colorectal tumors |
| 04/07/2005 | WO2003030612A3 Methods for modulating activity of the fxr nuclear receptor |
| 04/07/2005 | WO2003015783A8 Method of treating alcoholism or alcohol abuse |
| 04/07/2005 | US20050075511 Prevention of human and/or animal viral, bacterial, fungal or parasitic infections; plant fungicides, bactericides and/or herbicides; reduced side effects; environmentally friendly; such as ((n-formyl-n-hydroxyamino)-methoxy)-methyl phosphonic acid disodium salt |
| 04/07/2005 | US20050075489 DSP-5 dual-specificity phosphatase |
| 04/07/2005 | US20050075396 Modulation of type 2 diabetes and drug delivery |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075391 Nitric oxide donor composition and method for treatment of anal disorders |
| 04/07/2005 | US20050075380 Composition comprising at least one oxazolin for inhibiting langerhans cell migratio, and uses thereof |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals |
| 04/07/2005 | US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS |
| 04/07/2005 | US20050075350 Adding a pyridonecarboxylic acid comprising lomefloxacin, norfloxacin, ofloxacin, enoxacin, ciprofloxacin, tosufloxacin, fleroxacin and/or levofloxacin; cinoxacin, sparfloxacin or salt; low temperature; antiinflammatory agents |
| 04/07/2005 | US20050075349 Xanthine phosphodiesterase V inhibitors |
| 04/07/2005 | US20050075344 Melanocortin receptor agonists |
| 04/07/2005 | US20050075343 Benzimidazole derivatives as modulators of IgE |
| 04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |